Today, Corbus Pharmaceuticals announced that the European Commission has approved orphan designation for lenabasum in the treatment of dermatomyositis...
Tag Archive for: lenabasum
Corbus Pharmaceuticals announced today that they will proceed with a Phase 3 clinical trial to evaluate the efficacy and...
Choose your language
Helpful Resources
Upcoming Events
Sun
28
Monthly Necrotizing Myopathy Patient Video Support session
February 28 @ 3:00 pm - 4:30 pm EST